Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma April 25, 2024 UMSOM and UMB to lead Maryland’s Abortion Clinical Care Training Program with $10.6 million grant February 21, 2024 New nasal vaccine for COVID-19 shows promise in animal studies November 6, 2023
Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma April 25, 2024
UMSOM and UMB to lead Maryland’s Abortion Clinical Care Training Program with $10.6 million grant February 21, 2024